Found 21 matching trials
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer N/A Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Show More Location
Hunan Cancer hospital
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety NA This study aims to explore the effectiveness and safety of 125I seed implan...
Show More Location
Jiangxi Cancer Hospital
Learn More & Join Trial
Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment NA There is no definitive evidence regarding the therapeutic efficacy of PD-1 ...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer N/A To evaluate the safety and effectiveness of laparoscopic gastrectomy (LG) f...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma N/A The aim of this study is to the efficacy, prognosis, adverse effects, and f...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study N/A Immune checkpoint inhibitor (ICI), including programmed cell death protein-...
Show More Location
Cancer Center Sun Yat-sen University
Learn More & Join Trial
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure NA This study is a prospective, randomized controlled, multicenter clinical st...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer N/A This multicenter retrospective real-world study aims to evaluate the safety...
Show More Location
Peking University Cancer Hospital & Institute
Learn More & Join Trial
Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy PHASE3 Patients with stage III non-small-cell lung cancer initially evaluated as u...
Show More Location
Multiple Locations
Learn More & Join Trial